Synthetic Biologics Inc (SYN) - Analysis

United States

opens in 2d 4h 28m

005930 220,500.00 -2.43%
0700 469.20 -2.09%
2330 2,170.00 -0.46%
ASML 1,222.40 2.50%
AZN 13,512.00 -3.13%
ETH/USD 2,303.39 0.34%
EUR/USD 1.17 0.00%
MC 451.40 0.66%
NESN 78.73 -0.72%
USD/JPY 157.08 0.01%
XPT/USD 1,003.20 0.33%

005930 220,500.00 -2.43%
0700 469.20 -2.09%
2330 2,170.00 -0.46%
ASML 1,222.40 2.50%
AZN 13,512.00 -3.13%
ETH/USD 2,303.39 0.34%
EUR/USD 1.17 0.00%
MC 451.40 0.66%
NESN 78.73 -0.72%
USD/JPY 157.08 0.01%
XPT/USD 1,003.20 0.33%

005930 220,500.00 -2.43%
0700 469.20 -2.09%
2330 2,170.00 -0.46%
ASML 1,222.40 2.50%
AZN 13,512.00 -3.13%
ETH/USD 2,303.39 0.34%
EUR/USD 1.17 0.00%
MC 451.40 0.66%
NESN 78.73 -0.72%
USD/JPY 157.08 0.01%
XPT/USD 1,003.20 0.33%

005930 220,500.00 -2.43%
0700 469.20 -2.09%
2330 2,170.00 -0.46%
ASML 1,222.40 2.50%
AZN 13,512.00 -3.13%
ETH/USD 2,303.39 0.34%
EUR/USD 1.17 0.00%
MC 451.40 0.66%
NESN 78.73 -0.72%
USD/JPY 157.08 0.01%
XPT/USD 1,003.20 0.33%

0.38960001 USD

0.031

8.64%

Last update Apr 27, 3:59 PM EDT

Market closed

Day range

0.38960001

0.36010000

0.38990000

Previous close

0.35859999

Open

0.36700001

Access this stock data via API

Synthetic Biologics Inc

0.39

0.03

8.64%

Analysis

Recommendation

Buy

100%

Strong buy

Access /recommendations data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.

Analyst ratings

Firm	Date	Action
Maxim Group	Mar 12, 2021	Upgrade
Maxim Group	Oct 05, 2020	Downgrade
Griffin Securities	May 10, 2018	Downgrade

Access /analyst_ratings/light data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.